ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,929.75
-0.49%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. FS Development Corporation II (FSII)

  7. FS Development Corporation II (FSII) Noticias

FSII

FS Development Corporati... (FSII)

FS Development Corporation II
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:FSII
FechaHoraFuenteTítuloSímboloCompañía
05/06/202315:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FSIIFS Development Corporation II
02/06/202315:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FSIIFS Development Corporation II
05/05/202315:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FSIIFS Development Corporation II
21/04/202315:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FSIIFS Development Corporation II
20/04/202306:54Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FSIIFS Development Corporation II
20/04/202306:50Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FSIIFS Development Corporation II
14/03/202315:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:FSIIFS Development Corporation II
14/02/202316:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FSIIFS Development Corporation II
23/01/202315:23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FSIIFS Development Corporation II
23/01/202305:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FSIIFS Development Corporation II
18/01/202315:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:FSIIFS Development Corporation II
16/09/202215:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FSIIFS Development Corporation II
26/04/202205:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FSIIFS Development Corporation II
07/02/202215:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:FSIIFS Development Corporation II
28/01/202215:46Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:FSIIFS Development Corporation II
21/01/202215:29Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:FSIIFS Development Corporation II
30/12/202115:31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:FSIIFS Development Corporation II
27/12/202106:00GlobeNewswire Inc.Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19NASDAQ:FSIIFS Development Corporation II
23/12/202112:12Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:FSIIFS Development Corporation II
23/12/202110:16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FSIIFS Development Corporation II
21/12/202106:00Business WireFSII and Pardes Biosciences Move Towards Merger With the Goal of Tackling COVID-19 via an Oral Antiviral for Treatment and Prevention of SARS-CoV-2 InfectionsNASDAQ:FSIIFS Development Corporation II
01/12/202110:38Business WireFS Development Corp. II Announces Effectiveness of Registration Statement for Proposed Business Combination with Pardes Special Meeting Scheduled for December 23, 2021NASDAQ:FSIIFS Development Corporation II
23/11/202115:53Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:FSIIFS Development Corporation II
23/11/202115:38Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:FSIIFS Development Corporation II
26/08/202107:00GlobeNewswire Inc.Pardes Biosciences Initiates First-in-Human Trial for PBI-0451, an Oral Antiviral in Development to Treat and Prevent SARS-CoV-2 InfectionsNASDAQ:FSIIFS Development Corporation II
05/08/202106:00GlobeNewswire Inc.Pardes Biosciences Appoints Deborah M. Autor, J.D. and Laura J. Hamill to Board of DirectorsNASDAQ:FSIIFS Development Corporation II
29/06/202105:00Business WirePardes Biosciences & FS Development Corp. II Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Adv...NASDAQ:FSIIFS Development Corporation II
16/02/202120:36Business WireFS Development Corp. II, Sponsored by Foresite Capital, Announces Pricing of Upsized $175 Million Initial Public OfferingNASDAQ:FSIIFS Development Corporation II
11/10/201215:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:FSIIFS Development Corporation II
11/10/201215:49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:FSIIFS Development Corporation II
 Showing the most relevant articles for your search:NASDAQ:FSII

Su Consulta Reciente

AMEX
SPFF
Global X SuperIncome Pre...
EU
ALDVI
Advicenne
NASDAQ
SMCAPX
Smart Trust California M...
NASDAQ
LMTGE
DOWI
DJDXAHAP
DJ Developed Markets ExA...
BOV
L1MN34M
Lumen Technologies
NASDAQ
AAZZIXX
Hsbc Bank Usa Na All Up ...
BIT
F19799
Vontobel Financial Produ...
KUCN
NHCTUSDT
Hurricane NFT Token
COIN
GEXXETH
UNSW3
MEMDETH
MemeDAO
NYSE
CLNY-E.CL
Colony Capital
LSE
0S20
COIN
KNTJPY
LBNK
WNCGUSDT
Wrapped NCG
TSXV
MOO
Moon River Moly
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados